http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201416674-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9ffef270b97d6ddd2f04146ef226621 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
filingDate | 2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34bb6767faf37f57d9ca222ac517f508 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0806db05f3cc83871efcbf8648d8ec68 |
publicationDate | 2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201416674-A |
titleOfInvention | Method for screening candidate agents for breast cancer metastasis |
abstract | The invention relates to a method for screening a candidate for treating breast cancer metastasis, which comprises detecting whether a test substance can inhibit the secretion of CXCL5 by osteoblasts; and/or detecting whether the test substance can inhibit the secretion of CXCL5 by osteoblasts. The activity of Raf, MEK, ERK, MSK1, Elk-1, Snail, E-cadherin and/or fibroblast marker signaling chain in breast cancer cells. |
priorityDate | 2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 347.